✦ LIBER ✦

One-week triple therapy with esomeprazole, clarithromycin and metronidazole is highly effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance—a prospective randomized multicenter trial

✍ Scribed by Miehlke, Stephan; Ebert, Stefan; Kirsch, Christian; Schneider-Brachert, Wulf; Baestlein, Elke; Haferland, Christian; Neumeyer, Michael; Vieth, Michael; Stolte, Manfred; Lehn, Norbert; Bayerdoerffer, Ekkehard

Book ID: 121926275
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 178 KB
Volume: 124
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(03)81820-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Seven-day triple therapy with esomeprazo

Seven-day triple therapy with esomeprazole, rifabutin and amoxicillin is effective in eradicating Helicobacter pylori resistant to both metronidazole and clarithromycin—a prospective, randomized multicenter trial

✍ Miehlke, Stephan; Hansky, Kathrin; Schneider-Brachert, Wulf; Kirsch, Christian; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 176 KB

One-week ranitidine bismuth citrate-base

One-week ranitidine bismuth citrate-based low dose clarithromycin triple therapy is superior to omeprazole-based regime for the eradication of Helicobacter pylori (H. Pylori) in Hong Kong with high prevalence of metronidazole resistance

✍ Wong, Wai-Man; Wong, Bcy; Wang, Wh; Chu, Km; Lai, Kc; Hu, Whc; Fung, Fmy; Yuen, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Bismuth-Based Quadruple Therapy Using a

Bismuth-Based Quadruple Therapy Using a Single Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline Given With Omeprazole Versus Omeprazole, Amoxicillin, and Clarithromycin for Eradication of Helicobacter pylori in Duodenal Ulcer Patients: a Prospective, Randomized, Multicenter, North American Trial

✍ Laine, Loren; Hunt, Richard; El-Zimaity, Hala; Nguyen, Bich; Osato, Michael; Spe 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 61 KB

Efficacy and tolerability of first-line

Efficacy and tolerability of first-line triple therapy with levofloxacin and amoxicillin plus esomeprazole or rabeprazole for the eradication of Helicobacter pylori infection and the effect of CYP2C19 genotype: A 1-week, randomized, open-label study in chinese adults

✍ Xiaolin Pan; Yuqing Li; Yuping Qiu; Qiyun Tang; Bingbing Qian; Linhua Yao; Ruihu 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 117 KB